Results 91 to 100 of about 27,659 (257)

Immunization strategies targeting newly arrived migrants in Non-EU countries of the mediterranean basin and black sea [PDF]

, 2017
Background: The World Health Organization recommends that host countries ensure appropriate vaccinations to refugees, asylum seekers and migrants. However, information on vaccination strategies targeting migrants in host countries is limited. Methods: In
Declich, Silvia, Del Manso, Martina, Dente, Maria Grazia, Giambi, Cristina, Mediterranean Basin Black Sea, Montano-Remacha, Carmen, Napoli, Christian, Riccardo, Flavia   +7 more
core   +1 more source

Selecting the Most Effective Nudge: Evidence From a Large‐Scale Experiment on Immunization

Econometrica, Volume 93, Issue 4, Page 1183-1223, July 2025.
Policymakers often choose a policy bundle that is a combination of different interventions in different dosages. We develop a new technique—treatment variant aggregation (TVA)—to select a policy from a large factorial design. TVA pools together policy variants that are not meaningfully different and prunes those deemed ineffective.
Abhijit Banerjee, Arun G. Chandrasekhar, Suresh Dalpath, Esther Duflo, John Floretta, Matthew O. Jackson, Harini Kannan, Francine Loza, Anirudh Sankar, Anna Schrimpf, Maheshwor Shrestha   +10 more
wiley   +1 more source

Immunization Update, April 2008, Vol. 1, no. 7 [PDF]

, 2008
Monthly newsletter for the Iowa Department of Public ...

core  

Marburg Virus Disease: A Narrative Review

Health Science Reports, Volume 8, Issue 5, May 2025.
ABSTRACT Background and Aims Given the recent deadly outbreaks of the Marburg virus (MARV), in early 2023 in Tanzania and Equatorial Guinea, and the most recent one in Rwanda in 2024, there has been renewed attention across Africa on the threat posed by the re‐emergence of MARV as a growing concern for public health.
Arash Letafati, Somayeh Sadat Hosseini Fakhr, Ali Qaraee Najafabadi, Negin Karami, Hassan Karami   +4 more
wiley   +1 more source

Comparative study of antibody levels developed by vaccination against polio virus in population after vaccine type alteration [PDF]

, 2015
During clinical trials, samples from Hungarian patients of different age groups were tested for antibodies against all 3 serotypes of poliovirus, a member of Picornaviridae family.
Farkas, Ágnes, Magyar, Nóra, Szomor, Katalin, Takács, Mária   +3 more
core   +1 more source

A highly immunogenic UVC inactivated Sabin based polio vaccine

npj Vaccines
Despite their efficacy, the currently available polio vaccines, oral polio vaccine (OPV) and inactivated polio vaccine (IPV), possess inherent flaws posing significant challenges in the global eradication of polio.
Gregory J. Tobin, John K. Tobin, Taralyn J. Wiggins, Ruth V. Bushnell, Arina V. Kozar, Matthew F. Maale, David A. MacLeod, Heather N. Meeks, Michael J. Daly, Stephen J. Dollery   +9 more
doaj   +1 more source

Safety and Immunogenicity of Live Oral Cholera and Typhoid Vaccines Administered Alone or in Combination with Antimalarial Drugs, Oral Polio Vaccine, or Yellow Fever Vaccine [PDF]

, 2017
The effects of concomitant administration of antimalarial drugs, oral polio vaccine, or yellow fever vaccine on the immune response elicited by the Vibrio cholerae CVD103-HgR and Salmonella typhi Ty21a live oral vaccines were investigated. Healthy adults
Cryz, Stanley J., Herzog, Christian, Kollaritsch, Herwig, Kunz, Christian, Que, John U., Wiedermann, Gerhard   +5 more
core  

Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data. [PDF]

, 2016
BACKGROUND: Global withdrawal of serotype-2 oral poliovirus vaccine (OPV2) took place in April 2016. This marked a milestone in global polio eradication and was a public health intervention of unprecedented scale, affecting 155 countries.
Blake, Isobel M, Etsano, Andrew, Grassly, Nicholas C, Jafari, Hamid, Molodecky, Natalie A, O'Reilly, Kathleen M, Pons-Salort, Margarita, Safdar, Rana M, Vaz, Rui Gama, Wadood, Mufti Zubair   +9 more
core   +4 more sources

Extensive myelitis after oral polio vaccination: MRI features

Journal of the Belgian Society of Radiology, 2014
A 7-year-old boy presented with fever and ataxia 20 days after oral polio vaccination. Magnetic resonance imaging showed extensive myelitis, involving both anterior and posterior horns of the gray matter. Complete posttreatment recovery was evident. Postvaccinal myelitis after oral polio vaccination, of either infectious or immune mediated etiology, is
Kozic, D., Turkulov, V., Bjelan, M., Petrovic, K., Popovic-Petrovic, S., Vanhoenacker, Filip   +5 more
openaire   +6 more sources

Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to standard-dose diphtheria, tetanus, acellular pertussis when used as a pre-school booster in UK children : a 5-year follow-up of a randomised controlled study [PDF]

, 2015
This serological follow up study assessed the kinetics of antibody response in children who previously participated in a single centre, open-label, randomised controlled trial of low-dose compared to standard-dose diphtheria booster preschool ...
Baudin, M., Fiquet, A., John, T., Kitchin, N., McCarthy, Noel D., Pollard, A. J., Richard, P., Voysey, M., Yu, L. M.   +8 more
core   +1 more source